High expectations for science projects sharing €40m fund

The 24 successful projects include the development of a vaccine against the hospital-acquired infection methicillin-resistant staphylococcus (MRSA).
The awards range from €50,000 to €2.7m over four- to five-year periods. The money will support projects involving 200 researchers and 39 companies.